Concepedia

Author

Peng Liu

Chinese Academy of Medical Sciences & Peking Union Medical CollegeORCID

Also Known As

P Liu, Peng Liu, Youwu Shi

43

Publications

887

Citations

13

H-Index

29

Concepts

All Affiliations

Chinese Academy of Medical Sciences & Peking Union Medical CollegeBrandeis UniversityVA Boston Healthcare SystemGeorge Mason UniversityWayne State University
PL

About

Peng Liu is an author at Chinese Academy of Medical Sciences & Peking Union Medical College specializing in medicine, cell signaling, and cell biology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

169

2

Natural Sciences

2

2

55

3

Biochemistry

2

2

55

4

Cell Biology

2

2

55

5

Gastroenterology

1

1

104

Peng Liu

×

17

Publications

529

Citations

12

H-Index

YearCitations

Clinical features and outcomes of diffuse large B-cell lymphoma based on nodal or extranodal primary sites of origin: Analysis of 1,085 WHO classified cases in a single institution in China

Yuankai Shi, Ying Han, Jianliang Yang,

Chinese Journal of Cancer Research

2019

121

Primary non-Hodgkin lymphomas in the small and large intestine: clinicopathological characteristics and management of 40 patients

Bo Li, Yuankai Shi, Xiaohui He,

International Journal of Hematology

2008

104

Positive Regulation of Interleukin-1β Bioactivity by Physiological ROS-Mediated Cysteine S-Glutathionylation

Xue Zhang, Peng Liu, Christie Zhang,

Cell Reports

2017

43

Prognostic Nomogram for Overall Survival in Patients with Diffuse Large B-Cell Lymphoma

Ying Han, Jianliang Yang, Peng Liu,

The Oncologist

2019

42

Molecular Epidemiology of <i>Vibrio cholerae</i> O139 in China: Polymorphism of Ribotypes and CTX Elements

Mei Qu, Jing Xu, Yanpeng Ding,

Journal of Clinical Microbiology

2003

33

Mice lacking Axl and Mer tyrosine kinase receptors are susceptible to experimental autoimmune orchitis induction

Nan Li, Zhenghui Liu, Yue Zhang,

Immunology and Cell Biology

2014

31

Histone deacetylases inhibitor chidamide synergizes with humanized PD1 antibody to enhance T-cell chemokine expression and augment Ifn-γ response in NK-T cell lymphoma

Tingyu Wen, Guang-Yi Sun, Wenxin Jiang,

EBioMedicine

2022

25

Comparison of gemcitabin, cisplatin, and dexamethasone (GDP), CHOP, and CHOPE in the first-line treatment of peripheral T-cell lymphomas

Bo Jia, Shaoxuan Hu, Jianliang Yang,

Hematology

2016

21

Upfront radiation is essential for high-risk early-stage extranodal NK/T-cell lymphoma, nasal type: comparison of two sequential treatment modalities combining radiotherapy and GDP (gemcitabine, dexamethasone, and cisplatin) in the modern era

Fei Qi, Bo Chen, Jingjing Wang,

Leukemia & lymphoma/Leukemia and lymphoma

2019

20

Identification of key regulatory pathways of myeloid differentiation using an mESC-based karyotypically normal cell model

Dong Li, Hong Yang, Hong Nan,

Blood

2012

14

Page 1